Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 26931-26940 Newer>

The Motley Fool October 29, 2007 Dave Mock	Foolish Forecast: The View From Alvarion's Catbird Seat The wireless broadband systems developer is set to report its third-quarter earnings shortly. Investors, here's a preview of what to expect.
The Motley Fool October 29, 2007 Rick Aristotle Munarriz	United Online: Multiple Investing Personalities The online firm has plenty of surprises for investors.
The Motley Fool October 29, 2007 Sham Gad	Two Cornerstones of Value Investing Take note of these central concepts for investing intelligently.
The Motley Fool October 29, 2007 Anders Bylund	Microsoft Can Still Get Better Great quarter guys, but nobody's perfect. The online segment sticks out like a sore thumb. Investors, take note.
The Motley Fool October 29, 2007 Brian Lawler	Medicines Stopping the Bleeding The drugmaker outlines plans to grow its top and bottom lines. Investors, take note.
The Motley Fool October 29, 2007 Toby Shute	Precision Drilling's New Direction Though Precision has a commanding market share in Canada, it's not bound to keep its rigs there. The lower 48 is no promised land, but it's still promising. While the firm's rigs head south, it's doubtful its shares will follow suit.
The Motley Fool October 29, 2007 Tom Taulli	ICE Is Still Hot With global tensions, tight supplies, and a rising U.S. dollar, oil futures hit a record $93 per barrel today. It's no wonder InterContinental Exchange posted strong third-quarter numbers last week.
The Motley Fool October 29, 2007 Billy Fisher	The Drag on Reynolds American The tobacco company reports adjusted EPS growth of 12% versus its year-ago quarter. Reynolds American is still an attractive opportunity for income investors and value investors alike.
The Motley Fool October 29, 2007 Billy Fisher	Tarceva Sales Thrive at OSI The pharmaceutical's net revenue jumps 77%. Amazingly enough, there's still room for further growth at OSI. Investors, take note.
The Motley Fool October 29, 2007 Brian Orelli	Foolish Forecast: Tenacious Teva The generic drug maker releases earnings shortly. Here's a look at whether investors should expect a generic quarter or a blockbuster.
<Older 26931-26940 Newer> Return to current articles.